Vaccitech (NASDAQ:VACC) reported quarterly losses of $(1.90) per share.
Deutsche Bank Maintains Buy on CSX, Raises Price Target to $115
Deutsche Bank analyst Amit Mehrotra maintains CSX (NASDAQ:CSX) with a Buy and raises the price target from $113 to $115.